Eight patients underwent radiotherapy. Three patients received it as part of upfront therapy to facilitate resection, all with stage III disease. Two are survivors, one is lost to follow-up.  Four patients received it as part of relapse therapy. Two are survivors and two are dead. It was used with palliative intent in one patient, who failed chemotherapy and had an irresectable tumour.